The SOLACI Solidarity Program Celebrates 10 Years of Impact in Latin America

During the SOLACI-SOCIME 2025 Congress, a significant scientific session was held, organized by the SOL-SOLACI Program, aimed at reviewing the 10-year journey of the SOLACI Solidarity Program—an institutional responsibility initiative designed to help low-income patients in various regions of Latin America gain access to percutaneous procedures, with the support of devices provided by the medical industry.

The session, coordinated by Marcelo Halac (Argentina), Director of SOL-SOLACI, featured a distinguished panel of experts, including Alied Bencomo (Pan American Health Organization), José Luis Michelena (Médecins Sans Frontières), Rubén Piraíno (Argentina), and Mario Araya (Chile).

The event began with a presentation by Alied Bencomo (Mexico), who offered an updated overview of cardiovascular disease in Latin America, highlighting the growing burden of these conditions in the region and the urgent need for interventions to improve treatment access. Next, Marcelo Halac (Argentina) delivered a presentation on the Key Features of the SOLACI Solidarity Program, describing how the initiative has successfully carried out 98 percutaneous procedures for patients from disadvantaged communities, improving their quality of life.

Rubén Piraíno (Argentina) discussed Indicated vs. Actually Performed Interventional Practices in LATAM: A Practical Evaluation Exercise, in which he analyzed the gap between recommended practices and their implementation in the region, stressing the importance of optimizing processes to maximize public health impact. Subsequently, José Luis Michelena (Mexico), from Médecins Sans Frontières, presented The Concept of Institutional Social Responsibility as a Driver to Address Population Needs, reflecting on how inter-institutional cooperation can serve as a catalyst for improving access to essential health treatments in vulnerable communities.

Dr. Halac then presented a Summary of Solidarity Cases, sharing inspiring stories of patients whose lives were transformed thanks to procedures performed under this program.

The session concluded with an interactive discussion between speakers and attendees, highlighting the positive impact of the SOLACI Solidarity Program on the cardiovascular health of thousands of people in Latin America and underscoring the importance of institutional collaboration to continue improving access to percutaneous treatments in the region.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

Our webinar “SELUTION: Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives”, held on November 19, 2025 via Zoom with...

25/11 – SOLACI Webinar: Pulmonary Embolism in 2025 – Risk Stratification and Novel Therapeutic Approaches

The Latin American Society of Interventional Cardiology invites you to participate in a new virtual scientific event titled “Pulmonary Embolism (PE) in 2025: Risk...

SELUTION Sirolimus-Eluting Balloon For De Novo Coronary Lesions – New Evidence and Clinical Perspectives

The Latin American Society of Interventional Cardiology invites you to join a new virtual scientific event focused on the latest evidence and clinical perspectives...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Coronary perforations remain one of the most serious complications of percutaneous coronary intervention (PCI), especially in cases of Ellis ruptures type III. In these...

Is it really necessary to monitor all patients after TAVR?

Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

Is it really necessary to monitor all patients after TAVR?

Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....